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Screening of symptomatic infants for metabolic diseases i described which led to an improved detection rate 
because of better awareness and case selection, as well as the use of a test for urinary organic acids. 
We observed a marked increase during the past 2 years 
in the number of metabolic diseases detected at the 
Children's Hospital of Michigan, which is a 315-bed 
hospital with 14000 admissions per year. The reasons 
were therefore xplored. 
METHODS 
Until 1978 screening of symptomatic patients for meta- 
bolic diseases consisted of a number of simple chemical 
urine tests (MET) (Thomas and Howell, 1973) and 
amino acid paper chromatography (AA) (Mabry and 
Karan, 1964; Mabry and Todd, 1963). A gas chromato- 
graphic urine organic acid (OA) screen was then added 
(Schlenk and Gellerman, 1960; Najamura et al., 1976), 
inclusion of tests for ammonia (NH4), lactate (LA) and 
pyruvate (PA) was recommended, and criteria for selec- 
tive screening were developed. 
RESULTS 
With the joint MET and AA screen we performed 321 
tests per year in I978-9 and in the preceding 6 years 194 
tests per year. We detected four disorders per year, or 
one per 80 tests, compared to one per year and a 
detection rate of one per 194 tests before. During the 
i 
same 2 years 105 patients had urine OA screens. Four 
cases of methylmalonic a idaemia (MMAemia) and one 
glutaric acidaemia were diagnosed, giving a detection 
rate of one per 21 tests. In the preceding 6 years only one 
organic acidaemia was recognized. The high incidence 
of MMAemia in Michigan (five in 2 years, including one 
referral) was not due to unusual ethnic or family distri- 
bution. One-hundred and twenty-eight patients per year 
had tests of LA or LA and PA, and we established a 
positive diagnosis in two patients. No hyperammon- 
aemia was detected. OA thus added 2.5 cases per year to 
the yield of the MET and AA screen and LA, PA and 
NH 4 added one more per year. 
The following disorders were diagnosed: two non- 
ketotic hyperglycinaemias (McKusick 23830), one maple 
sugar urine disease (McKusick 24860), one arginino- 
succinic acidaemia (McKusick 20790), one tyrosinaemia 
(McKusick 27670), one B~z-responsive MMAemia 
(McKusick 25110), and three Bt2-unresponsive 
MMAemias (McKusick, 25100), one glutaric acidaemia 
(McKusick 23167), two fructose intolerances (McKusick 
22960), two pyruvate dehydrogenase deficiencies 
(McKusick 20880), and one Sanfilippo mucopolysac- 
charidosis (McKusick 25290); total: 15 cases. 
Unexplained catastrophic llness, episodic vomiting 
and/or acidosis and CNS depression were the presenting 
symptoms in 12 of 15 cases. A majority (8/15) had a 
clinical course characterized by intermittent illness re- 
quiring intensive care. Consequently, 10 of 15 cases were 
recognized in an intensive care unit, compared to two of 
eight in the preceding years. Customary methods for 
mass screening of newborns would not have detected 10 
of the 15 cases, because the disease was not associated 
with urine abnormality or the episodic nature caused 
abnormality only on occasions. Specific dietary or vita- 
min treatment was available in seven of 15 cases and five 
were treated successfully because of timely detection 
through screening. 
CONCLUSION 
As a result of intensified resident teaching, 1.63 times as 
many requests per year for routine metabolic screening 
tests (MET and AA) were received uring 1978-9, and 
four times as many disorders were detected than before. 
We attribute this to :
(1) greater awareness by the staff of metabolic disease 
in general; 
(2) better selection of symptomatic cases for screening, 
evidenced by an improved etection rate per test; 
(3) more screening in intensive care units where 66% of 
the cases were detected, compared to 25% before. 
Urine screening for OA by gas chromatography was 
partially responsible for the improved detection rate. 
Since four of the OAemias could have been detected by 
a simple chemical MMA screening test (Giorgio and 
Plant, 1965), routine use of such a test is recommended 
for screening of high risk infants. 
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